ENZIDE

Main information

Trade name:
ENZIDE 10 TAB

Active ingredient:
Enalapril Maleate,Hydrochlorthiazide

Available from:
Cadila Ph.

Dosage:
10,25;MG

Pharmaceutical form:
TAB

Composition:
10

Medicine domain:
Humans

Medicine type:
Allopathic drug

Documents

for the general public:
The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.

Request the information leaflet for the general public.

for healthcare professionals:
The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.

Request the information leaflet for healthcare professionals.

Localization

Available in:
India

Language:
English

Other information

Status

Source:
Central Drugs Standard Control Organization

Last update:
09-08-2016

The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.

Request the information leaflet for the general public.

Access to this document is only available to registered users.

Register now for full access

31-8-2018

Human medicines European public assessment report (EPAR): Pixuvri, pixantrone dimaleate, Revision: 18, Authorised

Europe - EMA - European Medicines Agency

1-8-2018

Veterinary medicine European public assessment report (EPAR): Apoquel, oclacitinib maleate, Revision: 4, Authorised

Europe - EMA - European Medicines Agency

18-2-2019

Pholcodine / biclotymol / chlorphenamine maleate : List of nationally authorised medicinal products - PSUSA/00010437201804

Europe - EMA - European Medicines Agency

19-12-2018

Enalapril: List of nationally authorised medicinal products - PSUSA/00001211/201803

Europe - EMA - European Medicines Agency

28-11-2018

Opinion/decision on a Paediatric investigation plan (PIP): Pixuvri,pixantrone (dimaleate), decision type: , therapeutic area: , PIP number: P/0227/2018

Europe - EMA - European Medicines Agency

21-11-2018

EU/3/17/1923 (Pfizer Europe MA EEIG)

EU/3/17/1923 (Active substance: Glasdegib maleate) - Transfer of orphan designation - Commission Decision (2018)7839 of Wed, 21 Nov 2018 European Medicines Agency (EMA) procedure number: EMA/OD/106/17/T/01

Europe -DG Health and Food Safety

10-9-2018

Enalapril / nitrendipine: List of nationally authorised medicinal products - PSUSA/00001213/201801

Europe - EMA - European Medicines Agency

30-7-2018

Apoquel (Zoetis Belgium S.A.)

Apoquel (Active substance: Oclacitinib maleate) - Centralised - Renewal - Commission Decision (2018)5153 of Mon, 30 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/V/C/2688/R/13

Europe -DG Health and Food Safety